SCHEMBL888299

SCHEMBL888299

Oc1cc2ccc3ccccc3c2cc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.68
HSD17B10 Q99714 4/20 0.68
HIF1A Q16665 1/20 0.68
CYP1B1 Q16678 1/20 0.68
TRPM4 Q8TD43 1/20 0.67
CYP2A6 P11509 1/20 0.57
TSHR P16473 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
PTPN22 Q9Y2R2 1/20 0.54
HPRT1 P00492 1/20 0.52
CYP1A2 P05177 3/20 0.52
NQO2 P16083 1/20 0.52
HPGD P15428 2/20 0.50
POLB P06746 1/20 0.50
ALOX5 P09917 1/20 0.48
USP2 O75604 1/20 0.48
PAK1 Q13153 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11726972 0.96 TRPM4 (0.68) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL31171122 0.88 ALDH1A1 (0.65) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL25412286 0.88 ALDH1A1 (0.65) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL7245676 0.83 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL23912230 0.83 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL27624854 0.82 HSD17B10 (0.70) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
Dibenz[A,H]Anthracene SCHEMBL156100 0.82 ALDH1A1 (1.00) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
Dibenz[A,H]Anthracene SCHEMBL29777008 0.82 ALDH1A1 (1.00) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
Dibenz[A,H]Anthracene SCHEMBL29392838 0.82 ALDH1A1 (1.00) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4
SCHEMBL4856624 0.82 ALDH1A1 (1.00) ALDH1A1HSD17B10HIF1ACYP1B1TRPM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514893-A Steroid compound, preparation method and application thereof 珂阑(上海)医药科技有限公司 2023-08-01 CN disclosed
CN-107109056-A Resin film formation composition and resin film 日产化学工业株式会社 2017-08-29 CN disclosed
US-9676907-B2 Methods and systems of graft polymerization on a functionalized substrate ASPEN RESEARCH CORPORATION (US) 2017-06-13 US disclosed
US-20160168331-A1 METHODS AND SYSTEMS OF GRAFT POLYMERIZATION ON A FUNCTIONALIZED SUBSTRATE JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2016-06-16 US disclosed
US-9267009-B2 Methods and systems of graft polymerization on a functionalized substrate ASPEN RESEARCH CORPORATION (US) 2016-02-23 US disclosed
CN-105061509-A Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers SHELL INT RESEARCH 2015-11-18 CN disclosed
US-9073810-B2 Catalyst systems for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2015-07-07 US disclosed
US-9073809-B2 Catalyst systems for the catalytic oligomerization of olefinic monomers SHELL OIL COMPANY (US) 2015-07-07 US disclosed
US-20140296366-A1 METHODS AND SYSTEMS OF GRAFT POLYMERIZATION ON A FUNCTIONALIZED SUBSTRATE ASPEN RESEARCH CORPORATION (US) 2014-10-02 US disclosed
US-20140296339-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY ACADIA PHARMACEUTICALS INC. 2014-10-02 US disclosed
US-20090018200-A1 COMPOSITION CONTAINING A PHENANTHRENOL L'OREAL (FR) 2009-01-15 US disclosed
WO-2008077908-A1 LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2008-07-03 WO disclosed
EP-0320227-B1 Method of preventing polymer-scale formation SHINETSU CHEMICAL CO (JP) 1994-09-07 EP disclosed
CN-1023324-C Method of preventing polymer-scale formation SHINETSU CHEMICAL CO (JP) 1993-12-29 CN disclosed
US-4933399-A COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-06-12 US disclosed
CN-1035118-A A kind of method that forms polymer-scale that stops SHINETSU CHEMICAL CO (JP) 1989-08-30 CN disclosed
EP-0320227-A2 Method of preventing polymer-scale formation Shin-Etsu Chemical Co., Ltd. (JP) 1989-06-14 EP disclosed
US-4250005-A Radiation cross-linked polyurethane foams SCOTT PAPER COMPANY (US) 1981-02-10 US disclosed
US-4051078-A CURING DAINICHI-NIPPON CABLES, LTD. (JA) 1977-09-27 US disclosed
US-4046744-A Thermosetting coatings based on ketoxime-blocked isocyanates and oxazolidines ROHM AND HAAS COMPANY (US) 1977-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018200-A1 COMPOSITION CONTAINING A PHENANTHRENOL CUTA, AHR, TYR ALDH1A1 4116/4885HSD17B10 3094/4885HIF1A 1832/4885
US-20140296339-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY SLC6A4, HTR4, GPR34 ALDH1A1 3075/4885HSD17B10 3677/4885HIF1A 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.